Thư viện tri thức trực tuyến
Kho tài liệu với 50,000+ tài liệu học thuật
© 2023 Siêu thị PDF - Kho tài liệu học thuật hàng đầu Việt Nam

Tài liệu Báo cáo khoa học: Structure-activity relationships of a-conotoxins targeting neuronal
Nội dung xem thử
Mô tả chi tiết
MINIREVIEW
Structure-activity relationships of a-conotoxins targeting neuronal
nicotinic acetylcholine receptors
Emma L. Millard, Norelle L. Daly and David J. Craik
Institute for Molecular Bioscience, University of Queensland, Brisbane, QLD, Australia
a-Conotoxins that target the neuronal nicotinic acetylcholine receptor have a range of potential therapeutic applications and are valuable probes for examining receptor
subtype selectivity. The three-dimensional structures of
about half of the known neuronal specific a-conotoxins have
now been determined and have a consensus fold containing a
helical region braced by two conserved disulfide bonds.
These disulfide bonds define the two-loop framework characteristic for a-conotoxins, CCXmCXnC, where loop 1
comprises four residues (m ¼ 4) and loop 2 between three
and seven residues (n ¼ 3, 6 or 7). Structural studies, particularly using NMR spectroscopy have provided an insight
into the role and spatial location of residues implicated in
receptor binding and biological activity.
Keywords: NMR; peptide; X-ray crystallography.
Introduction
As outlined in other articles in this series, the a-conotoxins
have a range of potential therapeutic applications and have
proved to be valuable pharmacological tools based on their
ability to selectively inhibit the nicotinic acetylcholine
receptor (nAChR) [1–3]. The focus of this review is on
the three-dimensional structures of a-conotoxins and the
progress made towards dissecting the features involved in
receptor subtype selectivity. In particular, a-conotoxins
targeting neuronal rather than muscle nAChRs will be
discussed. Muscle specific a-conotoxins have been covered
in other more general reviews [4–6]. There is much current
interest in various neuronal receptor subtypes implicated in
diverse neurological disorders such as Alzheimer’s disease
and epilepsy [7–9], and in the regulation of small-cell lung
carcinoma [10,11].
The sequences, subtype selectivity and potency of
a-conotoxins targeting neuronal nAChRs are given in
Table 1, together with information on their structural
characterization. The cysteine residues and disulfide connectivity are invariant throughout these sequences and
define a two-loop framework, CCXmCXnC (Xm and Xn
refer to the number of noncysteine residues), where the
loops correspond to the residues between successive cysteine
residues. The number of residues in the two loops (m/n) is
used to group the a-conotoxins into different frameworks.
ImI and ImII have a 4/3 framework and the other peptides
in Table 1 contain either a 4/6 or 4/7 framework. It is
interesting to note that although the majority of 4/6 and 4/7
a-conotoxins are selective for neuronal nAChRs, conotoxin
EI contains a 4/7 framework but binds to the muscle-type
nAChR [12].
The sequence conservation of the a-conotoxins extends
beyond the cysteine residues, with a Ser and Pro in loop 1
being highly conserved. However, there is a significant degree
of sequence variation in the remaining residues, particularly
in loop 2. It is this sequence diversity that provides the
exquisite selectivity that a-conotoxins display for various
nAChR subtypes (Table 1). Structures of neuronally active
a-conotoxins, in conjunction with activity studies, have
provided clues to understanding the complexity involved in
binding to the nAChR. A summary of this structural
information and the insights into structure-activity relationships of a-conotoxins is presented in this review.
Structural features of a-conotoxins
The three-dimensional structures of a-conotoxins have
been determined, primarily using NMR spectroscopy. It
is unusual for such small peptides to crystallize but a few
a-conotoxins have been amenable to analysis with X-ray
crystallography. To date no neuronally active conotoxins
have been structurally characterized using both techniques,
however, the neuromuscularly active conotoxin GI has been
studied using both methods and the structures overlay very
closely [13–15].
Despite the small size of a-conotoxins they have welldefined structures with a characteristic overall fold. With the
structures of more than half of the known neuronally active
a-conotoxins determined it is possible to determine the
consensus structural features. These features involve
restraints imposed by the conserved disulfide connectivity
and a helical region centred around Cys III. The helix
typically encompasses residues 5–12. A comparison of the
known structures is given in Fig. 1 with the three framework
classes presented separately for clarity. It is clear that the
backbone fold of loop 1 is highly conserved, including the
first turn of the helix. The major differences, as might be
Correspondence to D. Craik, Institute for Molecular Bioscience,
University of Queensland, Brisbane, QLD, 4072, Australia.
Fax: + 61 73346 2029, Tel.: + 61 73346 2019,
E-mail: [email protected]
Abbreviation: nAChR, nicotinic acetylcholine receptor.
(Received 22 January 2004, revised 19 March 2004,
accepted 6 April 2004)
Eur. J. Biochem. 271, 2320–2326 (2004) FEBS 2004 doi:10.1111/j.1432-1033.2004.04148.x